Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 12(1): 198, 2022 01 07.
Article in English | MEDLINE | ID: mdl-34997004

ABSTRACT

Transcranial direct current stimulation (tDCS) is an emerging noninvasive brain neuromodulation technique aimed at relieving symptoms associated with psychiatric disorders, including addiction. The goal of the present study was to better identify which phase of alcohol-related behavior (hedonic effect, behavioral sensitization, self-administration, or motivation to obtain the drug) might be modulated by repeated anodal tDCS over the frontal cortex (0.2 mA, 20 min, twice a day for 5 consecutive days), using female mice as a model. Our data showed that tDCS did not modulate the hedonic effects of ethanol as assessed by a conditioned place preference test (CPP) or the expression of ethanol-induced behavioral sensitization. Interestingly, tDCS robustly reduced reacquisition of ethanol consumption (50% decrease) following extinction of self-administration in an operant paradigm. Furthermore, tDCS significantly decreased motivation to drink ethanol on a progressive ratio schedule (30% decrease). Taken together, our results show a dissociation between the effects of tDCS on "liking" (hedonic aspect; no effect in the CPP) and "wanting" (motivation; decreased consumption on a progressive ratio schedule). Our tDCS procedure in rodents will allow us to better understand its mechanisms of action in order to accelerate its use as a complementary and innovative tool to help alcohol-dependent patients maintain abstinence or reduce ethanol intake.


Subject(s)
Alcohol Drinking/prevention & control , Behavior, Animal , Drug-Seeking Behavior , Ethanol/administration & dosage , Motivation , Transcranial Direct Current Stimulation , Alcohol Drinking/adverse effects , Alcohol Drinking/psychology , Animals , Conditioning, Operant , Ethanol/toxicity , Extinction, Psychological , Female , Mice , Models, Animal , Self Administration
2.
Addict Biol ; 25(6): e12833, 2020 11.
Article in English | MEDLINE | ID: mdl-31762127

ABSTRACT

Ethanol-induced behavioral sensitization (EIBS) is thought to play a key role in addiction. However, whether EIBS is linked to an increase in the motivation to self-administerethanol in an operant paradigm has never been demonstrated, and thus, the motivational sensitization theory (increase in drug wanting) has not been yet confirmed. We investigated using the operant ethanol self-administrationparadigm if the motivation to self-administerethanol (breakpoint) is increased in female mice prone to develop EIBS. Outbred female Swiss mice were treated once a day with 2.5-g ethanol per kilogram during 10 days and challenged with the same dose of ethanol 7 days later. EIBS-pronegroup was characterized by a significant increase in locomotion between the challenge day and day 1. When the difference was not significant, mice were considered as the "EIBS-resistant"group. Mice were then trained to nose poke for a 20% ethanol solution reinforcer under a FR1 and then a FR-2schedule of reinforcement. Motivation was assessed more directly with a progressive ratio schedule. Our results show that there is a positive correlation between EIBS and both the level of intake and motivation. Interestingly, acquisition of ethanol self-administrationwas faster in sensitized mice that also display a quick and long-lastingincrease in ethanol intake together with a lack of effect of alcohol challenge on c-Fosexpression restricted to the dorsolateral striatum. These results further support that EIBS vulnerability is crucial in the development of addictive behaviors and suggest a potential link with habit learning processes.


Subject(s)
Alcohol Drinking/psychology , Ethanol/administration & dosage , Motivation/drug effects , Animals , Conditioning, Operant , Corpus Striatum/drug effects , Ethanol/pharmacology , Female , Locomotion , Motor Activity/drug effects , Proto-Oncogene Proteins c-fos/metabolism , Reinforcement, Psychology , Self Administration
3.
Addict Biol ; 20(3): 490-9, 2015 May.
Article in English | MEDLINE | ID: mdl-24725220

ABSTRACT

Schizophrenia is a mental disorder characterized by a series of positive, negative or cognitive symptoms but with also the particularity of exhibiting a high rate of co-morbid use of drugs of abuse. While more than 80% of schizophrenics are smokers, the second most consumed drug is alcohol, with dramatic consequences on frequency and intensity of psychotic episodes and on life expectancy. Here we investigated the impact of light alcohol intake during adolescence on the subsequent occurrence of alcohol addiction-like behavior in neonatal ventral hippocampal lesion (NVHL) rats, a neurodevelopmental model of schizophrenia. Our findings demonstrated an increased liability to addictive behaviors in adult NVHL rats after voluntary alcohol intake during adolescence. NVHL rats displayed several signs of alcohol use disorder such as a loss of control over alcohol intake and high motivation to consume alcohol, associated with a higher resistance to extinction. In addition, once NVHL rats relapsed, they maintained higher drinking levels than controls. We finally showed that the anti-addictive drug naltrexone is efficient in reducing excessive alcohol intake in NVHL rats. Our results are in accordance with epidemiological studies underlying the particular vulnerability to alcohol addiction after adolescent exposure to alcohol and highlight the fact that schizophrenic subjects may be particularly at risk even after light alcohol consumption. Based on these results, it seems particularly relevant to prevent early onset of alcohol use in at-risk subjects and thus to reduce the incidence of co-morbid alcohol abuse in psychotic patients.


Subject(s)
Alcohol Drinking/adverse effects , Alcoholism/etiology , Schizophrenia/complications , Alcohol Drinking/prevention & control , Alcoholism/prevention & control , Animals , Animals, Newborn , Central Nervous System Depressants/pharmacology , Conditioning, Operant , Disease Models, Animal , Drug-Seeking Behavior/drug effects , Ethanol/pharmacology , Hippocampus/physiology , Male , Naltrexone/pharmacology , Narcotic Antagonists/pharmacology , Rats, Sprague-Dawley
4.
Addict Biol ; 19(2): 210-24, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24164956

ABSTRACT

Ethanol (EtOH)-induced behavioral sensitization (EIBS) is proposed to play a role in early and recurring steps of alcohol dependence, but its impact on alcohol abuse is not clear. EIBS development is dependent upon animal species, strain and also individual factors. We proposed here to decipher the co-expression of EIBS and EtOH intake in individual animals among outbred Swiss mice, which exhibit heterogeneity that parallels what may occur in humans. To do so, mice were exposed to a two-bottle choice with free access to water or 10% EtOH for 6 days just before and immediately after chronic intraperitoneal 2.5 g/kg ethanol injections once a day for 10 consecutive days. Based on their sensitization scores, mice were split into resistant and sensitized animals. First, we showed that individual susceptibility to EIBS is inversely correlated with voluntary EtOH consumption. Exposure to repeated EtOH during EIBS development increased subsequent EtOH intake among the entire population. Very interestingly, subsequent analyses suggested that the less the mice are sensitized the more they increase their EtOH intake; however, resistant mice were sensitive to EtOH adulteration with quinine, whereas sensitized ones maintained their EtOH intake levels, therefore exhibiting a compulsive-like drinking pattern. In addition, we showed that resistant mice do not exhibit a weaker sensitivity to the aversive properties of EtOH that may contribute to their higher level of EtOH intake compared to sensitized mice. This study confirms and extends previous data showing a deep relationship between propensity for EtOH consumption and susceptibility to EIBS in Swiss mice.


Subject(s)
Alcohol Drinking/physiopathology , Central Nervous System Depressants/pharmacology , Ethanol/pharmacology , Food Preferences , Motor Activity/drug effects , Analysis of Variance , Animals , Animals, Outbred Strains , Central Nervous System Depressants/administration & dosage , Central Nervous System Depressants/metabolism , Choice Behavior/drug effects , Compulsive Behavior , Conditioning, Psychological , Disease Susceptibility , Dose-Response Relationship, Drug , Ethanol/administration & dosage , Ethanol/metabolism , Female , Injections, Intraperitoneal , Linear Models , Mice , Quinine/administration & dosage , Self Administration , Sodium Chloride/administration & dosage , Species Specificity
5.
Addict Biol ; 19(5): 758-69, 2014 Sep.
Article in English | MEDLINE | ID: mdl-23414063

ABSTRACT

Brain-derived neurotrophic factor (BDNF) within the striatum is part of a homeostatic pathway regulating alcohol consumption. Memantine, a non-competitive antagonist of N-methyl-D-aspartate receptors, induces expression of BDNF in several brain regions including the striatum. We hypothesized that memantine could decrease ethanol (EtOH) consumption via activation of the BNDF signalling pathway. Effects of memantine were evaluated in Long-Evans rats self-administering moderate or high amounts of EtOH 6, 30 and 54 hours after an acute injection (12.5 and 25 mg/kg). Motivation to consume alcohol was investigated through a progressive ratio paradigm. The possible role for BDNF in the memantine effect was tested by blockade of the TrkB receptor using the pharmacological agent K252a and by the BDNF scavenger TrkB-Fc. Candidate genes expression was also assessed by polymerase chain reaction array 4 and 28 hours after memantine injection. We found that memantine decreased EtOH self-administration and motivation to consume EtOH 6 and 30 hours post-injection. In addition, we found that inhibition or blockade of the BDNF signalling pathway prevented the early, but not the delayed decrease in EtOH consumption induced by memantine. Finally, Bdnf expression was differentially regulated between the early and delayed timepoints. These results demonstrate that an acute injection of memantine specifically reduces EtOH self-administration and motivation to consume EtOH for at least 30 hours. Moreover, we showed that BDNF was responsible for the early effect, but that the delayed effect was BDNF-independent.


Subject(s)
Alcohol Drinking/prevention & control , Brain-Derived Neurotrophic Factor/physiology , Excitatory Amino Acid Antagonists/pharmacology , Memantine/pharmacology , Animals , Brain-Derived Neurotrophic Factor/metabolism , Carbazoles/pharmacology , Central Nervous System Depressants/pharmacology , Corpus Striatum/drug effects , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Ethanol/pharmacology , Excitatory Amino Acid Antagonists/administration & dosage , Indole Alkaloids/pharmacology , Injections , Male , Memantine/administration & dosage , Motivation/drug effects , Prefrontal Cortex/drug effects , Rats, Long-Evans , Receptor, trkB/antagonists & inhibitors , Self Administration , Signal Transduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...